Share Email Print

Proceedings Paper

Biochemical responses of isolated lung CSCs after application of low intensity laser irradiation
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Studies have shown that using high fluences of Low Intensity Laser Irradiation (HF-LILI) produce apoptotic effects on normal and neoplastic cells. This study aimed to determine whether HF-LILI induce cell death in lung CSCs. Lung CSCs were isolated using the stem cell marker CD 133, characterized using flow cytometry, and applied in experiments which included treatment with LILI at wavelengths of 636, 825 and 1060 nm with fluences ranging from 5 J/cm2 to 40 J/cm2. Viability and proliferation studies, using Alamar blue assay and adenosine triphosphate luminescence (ATP), indicated an increase when treating lung CSCs with low fluences of 5 - 20 J/cm2 and a decrease in viability and proliferation as well as an increase in apoptosis when applying a fluence of 40 J/cm2 indicated by flow cytometry using Annexin V and propidium iodide (PI) dyes. Results indicate that LILI, when treating lung CSCs, can induce either a bio-stimulatory or bio-inhibitory effect depending on the wavelength and fluence used. This study indicated successful apoptotic induction of lung CSCs. Future experiments should be able to conclude the exact mechanism behind HF-LILI, which can be used in the targeted treatments of CSC elimination, implementing HF-LILI in the same manner as PDT in the absence of a photosensitizer.

Paper Details

Date Published: 8 March 2016
PDF: 12 pages
Proc. SPIE 9695, Mechanisms of Photobiomodulation Therapy XI, 96950J (8 March 2016); doi: 10.1117/12.2228902
Show Author Affiliations
Heidi Abrahamse, Univ. of Johannesburg (South Africa)
Anine Crous, Univ. of Johannesburg (South Africa)

Published in SPIE Proceedings Vol. 9695:
Mechanisms of Photobiomodulation Therapy XI
Michael R. Hamblin; James D. Carroll; Praveen Arany, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?